Contributor Content In his years as Director of Surgical Neuro-Oncology at the University of Southern California (USC), Dr. Thomas Chen has witnessed countless innovations in the world of cancer ...

In a quest to understand complex speech, scientists inserted what's been dubbed a human “language gene” into mice. Remarkably ...

In this video, Annick Desjardins, MD, professor of neurosurgery, professor of neurology and member of the Duke Cancer Institute, discusses what she is most looking forward to in the future of ...

Canadian researchers have developed an effective new technique for identifying aggressive medulloblastoma—the most common ...

Research presented at the NAPNAP National Conference on Pediatric Health Care explores the benefits of consistent, timely integration of palliative care services at a pediatric neuro-oncology clinic.

A drug developed at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has been shown to ...

Canadian researchers have developed an effective new technique for identifying aggressive medulloblastoma-the most common type of malignant brain tumour in children-and potentially sparing young ...

Researchers from the University of Texas Health Science Center at San Antonio have developed a drug that more than doubled median survival time and progression-free time for patients with glioblastoma ...

High-dose methotrexate (HD-MTX) with the modified Bonn protocol including intrathecal therapy is effective for patients less than 65 years old with primary central nervous system lymphoma (PCNSL), ...

Canadian researchers have developed an effective new technique for identifying aggressive medulloblastoma—the most common type of malignant brain tumour in children—and potentially sparing young ...